Olivier Leger

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 10 CIPO patents and 7 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Novimmune Sa, Novimmunie S.a., Novlmmune S.a.. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Leger. Retrieved from https://idiyas.com/inventor/olivier-leger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 89.3

CIPO Patents = 10 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 323(Granted Patents)

Company Filing History:

Years Active: 2010-2023

Loading Chart...

Areas of Expertise:

Anti-IL-6 Antibodies

Anti-CD3 Antibodies

Neutralizing Antibodies

Fc Receptor-Binding Polypeptides

Anti-Interferon Gamma Antibodies

Autoimmune Diseases

Nucleic Acid Encoding

Anti-IL-17A/IL-17F Antibodies

TLR4/MD2 Antibodies

Therapeutic Methods

Cross-Reactive Antibodies

Polypeptide Modifications

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11613582 - Anti-IL-6/IL-6R antibodies and methods of use thereof (2023-03-28),

2. 10844132 - Neutralizing antibodies and methods of use thereof (2020-11-24),

3. 10759862 - Anti-IL-6/IL-6R antibodies and methods of use thereof (2020-09-01),

4. 10759858 - Anti-CD3 antibodies and methods of use thereof (2020-09-01),

5. 10023646 - Neutralizing antibodies and methods of use thereof (2018-07-17),

6. 9850304 - Anti-CD3 antibodies and methods of use thereof (2017-12-26),

7. 9828430 - Anti-IL-6/IL-6R antibodies (2017-11-28),

8. 9688755 - Fc receptor-binding polypeptides with modified effector functions (2017-06-27),

9. 9682142 - Anti-interferon gamma antibodies and methods of use thereof (2017-06-20),

10. 9650437 - Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies (2017-05-16),

11. 9540444 - Neutralizing antibodies and methods of use thereof (2017-01-10),

12. 9534049 - Neutralizing antibodies and methods of use thereof (2017-01-03),

13. 9234034 - Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies (2016-01-12),

14. 8771697 - Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies (2014-07-08),

15. 8715669 - Anti-IL-17A/IL-17F cross-reactive antibodies (2014-05-06),

Title: Inventor Olivier Leger - Revolutionizing Technology in St. Sixt, FR

Introduction: Olivier Leger, a visionary inventor hailing from St. Sixt, FR, is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Olivier Leger holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Olivier Leger has worked tirelessly to develop cutting-edge solutions that have revolutionized industries worldwide. His commitment to pushing the boundaries of innovation has earned him recognition as a pioneer in his field.

Collaborations: Throughout his career, Olivier Leger has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with diverse teams has been instrumental in the success of his projects.

Conclusion: Olivier Leger's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.